Cargando…
Metformin Influence on the Intestinal Microbiota and Organism of Rats with Metabolic Syndrome
Metformin is a first-line drug for DM2 treatment and prevention, but its complex effect on impaired glucose tolerance (IGT), including its influence on myocardial resistance to ischemia-reperfusion injury, is not completely studied. We aimed to evaluate the influence of metformin on the intestinal m...
Autores principales: | Ermolenko, Elena, Simanenkova, Anna, Voropaeva, Lyubov, Lavrenova, Nadezhda, Kotyleva, Maryna, Minasian, Sarkis, Chernikova, Alena, Timkina, Natalya, Gladyshev, Nikita, Dmitriev, Alexander, Suvorov, Alexander, Galagudza, Michael, Karonova, Tatiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224185/ https://www.ncbi.nlm.nih.gov/pubmed/35743280 http://dx.doi.org/10.3390/ijms23126837 |
Ejemplares similares
-
Comparative evaluation of metformin and liraglutide cardioprotective effect in rats with impaired glucose tolerance
por: Simanenkova, Anna, et al.
Publicado: (2021) -
Consortium of Indigenous Fecal Bacteria in the Treatment of Metabolic Syndrome
por: Ermolenko, Elena, et al.
Publicado: (2022) -
Autoprobiotics as an Approach for Restoration of Personalised Microbiota
por: Suvorov, Alexander, et al.
Publicado: (2018) -
Gut Digestive Function and Microbiome after Correction of Experimental Dysbiosis in Rats by Indigenous Bifidobacteria
por: Gromova, Lyudmila V., et al.
Publicado: (2021) -
Myocardial protection against global ischemia with Krebs-Henseleit buffer-based cardioplegic solution
por: Minasian, Sarkis M, et al.
Publicado: (2013)